FNY Investment Advisers LLC Makes New $613,000 Investment in Doximity, Inc. (NASDAQ:DOCS)

FNY Investment Advisers LLC bought a new stake in Doximity, Inc. (NASDAQ:DOCSFree Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 11,500 shares of the company’s stock, valued at approximately $613,000.

Other hedge funds have also modified their holdings of the company. FMR LLC raised its holdings in Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after purchasing an additional 1,598,602 shares in the last quarter. Lord Abbett & CO. LLC purchased a new stake in shares of Doximity in the third quarter valued at about $29,453,000. Los Angeles Capital Management LLC boosted its stake in shares of Doximity by 6,242.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company’s stock worth $28,359,000 after purchasing an additional 640,612 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Doximity in the 3rd quarter valued at $24,691,000. Finally, Geode Capital Management LLC grew its holdings in Doximity by 19.8% in the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after buying an additional 472,565 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DOCS has been the subject of several research reports. Stephens started coverage on shares of Doximity in a research note on Friday, December 20th. They set an “equal weight” rating and a $55.00 price objective for the company. KeyCorp decreased their target price on Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Robert W. Baird increased their price objective on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 17th. Evercore ISI boosted their price target on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Finally, Baird R W upgraded Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. Thirteen analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $53.12.

Check Out Our Latest Analysis on Doximity

Doximity Trading Down 5.0 %

Doximity stock opened at $49.50 on Tuesday. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75. The company has a market capitalization of $9.24 billion, a PE ratio of 56.90, a P/E/G ratio of 4.13 and a beta of 1.40. The stock has a 50-day moving average price of $53.23 and a two-hundred day moving average price of $41.93.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.